Literature DB >> 35343849

Kidney stone formation in a novel murine model of polycystic kidney disease.

Heather A L Riddle1, Shiqin Zhang1, Feng Qian2, James C Williams3, Jason R Stubbs1,4, Peter Stanley N Rowe1,4, Stephen C Parnell1,5.   

Abstract

Individuals with autosomal dominant polycystic kidney disease have a higher incidence of stone formation than the general population. However, there are no cystic animal models known to develop stones. Cystic mice compound heterozygous for hypomorphic Pkd1V and Pkd1RC alleles develop cystic kidneys within a few weeks of birth but live beyond 20 wk of age, allowing for the study of cystic comorbidities including stone formation. Cystic Pkd1V/RC mice were euthanized at 3, 13, or 26 wk of age, and their kidneys were analyzed by microcomputed tomography (µCT) for stone formation. Mice had occasional mineral aggregates that could be detected by µCT analysis at 3 wk of age. At 13 or 26 wk of age, numerous white masses were visible beneath the kidney surface. µCT analysis confirmed the masses to be large mineral stone deposits throughout the renal cortex, with mineral content increasing with age. Staining of histological sections with alizarin red and von Kossa suggested that the stone deposits were composed primarily of calcium and phosphate. Microdissection confirmed stones localized within cyst lumens. Analysis of individual stones by µCT and infrared spectroscopy confirmed apatite mineral composition. Urinalysis revealed elevated levels of phosphate and citrate at 3 wk of age and lower pH and elevated levels of calcium and citrate at 13 wk of age, suggesting altered phosphate and calcium homeostasis as a potential cause of mineralization and renal stone formation. This is the first animal model exhibiting overt kidney stone formation in the context of cystic kidney disease.NEW & NOTEWORTHY Compound heterozygous Pkd1V/RC mice were found to form calcium phosphate-containing stones within cysts of the renal cortex by 13 wk of age. This is the first polycystic kidney disease animal model exhibiting spontaneous stone formation. A growing body of evidence suggests a link between renal stone formation and cystic kidney disease. This mouse model may be useful for studying the interplay between stone and cyst formation and the functional role of polycystins in mineral homeostasis.

Entities:  

Keywords:  autosomal dominant polycystic kidney disease; kidney stones; nephrolithiasis; polycystic kidney disease; polycystin-1

Mesh:

Substances:

Year:  2022        PMID: 35343849      PMCID: PMC9236864          DOI: 10.1152/ajprenal.00165.2021

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  32 in total

1.  Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel.

Authors:  S González-Perrett; K Kim; C Ibarra; A E Damiano; E Zotta; M Batelli; P C Harris; I L Reisin; M A Arnaout; H F Cantiello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  A micropuncture study of renal phosphate transport in rats with chronic renal failure and secondary hyperparathyroidism.

Authors:  N Bank; W S Su; H S Aynedjian
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

3.  Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure.

Authors:  Shengqiang Yu; Karl Hackmann; Jiangang Gao; Jianggang Gao; Xiaobing He; Klaus Piontek; Miguel A García-González; Miguel A García González; Luis F Menezes; Hangxue Xu; Gregory G Germino; Jian Zuo; Feng Qian
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

4.  Do ASARM peptides play a role in nephrogenic systemic fibrosis?

Authors:  Peter S N Rowe; Lesya V Zelenchuk; Jennifer S Laurence; Phil Lee; William M Brooks; Ellen T McCarthy
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-02

5.  Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

Authors:  José L Nishiura; Rodrigo F C A Neves; Samara R M Eloi; Susan M L F Cintra; Sergio A Ajzen; Ita P Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

6.  Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.

Authors:  Valentin David; Aline Martin; Anne-Marie Hedge; Peter S N Rowe
Journal:  Endocrinology       Date:  2009-06-11       Impact factor: 4.736

7.  Primary cilia are specialized calcium signalling organelles.

Authors:  Markus Delling; Paul G DeCaen; Julia F Doerner; Sebastien Febvay; David E Clapham
Journal:  Nature       Date:  2013-12-12       Impact factor: 49.962

8.  The ion channel function of polycystin-1 in the polycystin-1/polycystin-2 complex.

Authors:  Zhifei Wang; Courtney Ng; Xiong Liu; Yan Wang; Bin Li; Parul Kashyap; Haroon A Chaudhry; Alexis Castro; Enessa M Kalontar; Leah Ilyayev; Rebecca Walker; R Todd Alexander; Feng Qian; Xing-Zhen Chen; Yong Yu
Journal:  EMBO Rep       Date:  2019-08-22       Impact factor: 8.807

9.  Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Mireille El Ters; Pengcheng Lu; Jonathan D Mahnken; Jason R Stubbs; Shiqin Zhang; Darren P Wallace; Jared J Grantham; Arlene B Chapman; Vicente E Torres; Peter C Harris; Kyongtae Ty Bae; Douglas P Landsittel; Frederic F Rahbari-Oskoui; Michal Mrug; William M Bennett; Alan S L Yu
Journal:  Kidney Int Rep       Date:  2021-01-16

10.  High Prevalence of Kidney Cysts in Patients With CYP24A1 Deficiency.

Authors:  Christian Hanna; Theodora A Potretzke; Andrea G Cogal; Yaman G Mkhaimer; Peter J Tebben; Vicente E Torres; John C Lieske; Peter C Harris; David J Sas; Dawn S Milliner; Fouad T Chebib
Journal:  Kidney Int Rep       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.